Cargando…

Where Enhanced Recovery after Surgery (ERAS) Protocols Meet the Three Major Current Pandemics: COVID-19, Obesity and Malignancy

SIMPLE SUMMARY: The SARS-CoV-2 (COVID-19) pandemic has significantly modified the medical services provided for patients that receive care either for COVID-19 or for those that need care for benign diseases, including obesity, or for malignant ones, such as gynecological cancer. We sought to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prodromidou, Anastasia, Koulakmanidis, Aristotelis-Marios, Haidopoulos, Dimitrios, Nelson, Gregg, Rodolakis, Alexandros, Thomakos, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996966/ https://www.ncbi.nlm.nih.gov/pubmed/35406432 http://dx.doi.org/10.3390/cancers14071660

Ejemplares similares

Fertility-Sparing Treatment for Young Patients with Early-Stage Cervical Cancer: A Dawn of a New Era
por: Theofanakis, Charalampos, et al.
Publicado: (2022)

Clinicopathological Characteristics and Outcomes of Patients With Endometriosis-Related Hemorrhagic Ascites: An Updated Systematic Review of the Literature
por: Pandraklakis, Anastasios, et al.
Publicado: (2022)

Endometriosis of the Canal of Nuck: A Systematic Review of the Literature
por: Prodromidou, Anastasia, et al.
Publicado: (2020)

Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility
por: Rodolakis, Ioannis, et al.
Publicado: (2023)

Enhanced Recovery After Surgery Protocols in Obese Gynecological Oncology Patients: A Single-Center Experience
por: Pandraklakis, Anastasios, et al.
Publicado: (2023)

Preoperative Bowel Preparation in Minimally Invasive and Vaginal Gynecologic Surgery
por: Diakosavvas, Michail, et al.
Publicado: (2020)

Factors That Affect Survival Outcomes in Patients with Endometrial Clear Cell Carcinoma
por: Pergialiotis, Vasilios, et al.
Publicado: (2022)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
por: Liontos, Michalis, et al.
Publicado: (2021)

Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis
por: Pergialiotis, Vasilios, et al.
Publicado: (2022)

Identification and Biopsy of Sentinel Lymph Node in Early-Stage Cervical Carcinoma: Diagnostic Accuracy and Clinical Utility
por: Koutroumpa, Ioanna, et al.
Publicado: (2022)

Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature
por: Pergialiotis, Vasilios, et al.
Publicado: (2019)

Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology
por: Panagakis, Georgios, et al.
Publicado: (2023)

Is There a Role of Elevated CA 19-9 Levels in the Evaluation of Clinical Characteristics of Mature Cystic Ovarian Teratomas? A Systematic Review and Meta-analysis
por: Prodromidou, Anastasia, et al.
Publicado: (2019)

Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
por: Kyriazoglou, Anastasios, et al.
Publicado: (2018)

What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
por: Liontos, Michalis, et al.
Publicado: (2021)

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023)

Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature
por: Theofanakis, Charalampos, et al.
Publicado: (2016)

Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome?
por: Thomakos, Nikolaos, et al.
Publicado: (2018)

The Post COVID-19 Surgical Backlog: Now is the Time to Implement Enhanced Recovery After Surgery (ERAS)
por: Ljungqvist, Olle, et al.
Publicado: (2020)

The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
por: Trachana, Sofia-Paraskevi, et al.
Publicado: (2016)

405 The lockdown effect on gynaecological cancer surgeries during the COVID-19 Pandemic
por: Theodoulidis, V., et al.
Publicado: (2022)

Anterior pelvic exenteration for exstrophic bladder adenocarcinoma: Case report and review
por: Kathopoulis, Nikolaos, et al.
Publicado: (2016)

Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature
por: Thomakos, Nikolaos, et al.
Publicado: (2019)

Quantitative biology: where modern biology meets physical sciences
por: Shekhar, Shashank, et al.
Publicado: (2014)

Maximal Effort Cytoreduction in Epithelial Ovarian Cancer: Perioperative Complications and Survival Outcomes from a Retrospective Cohort
por: Haidopoulos, Dimitrios, et al.
Publicado: (2023)

Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
por: Xue, Fang, et al.
Publicado: (2023)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes
por: Simou, Maria, et al.
Publicado: (2011)

Where Next for Microbiome Research?
por: Waldor, Matthew K., et al.
Publicado: (2015)

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
por: Liontos, Michalis, et al.
Publicado: (2021)

Radical abdominal trachelectomy and pelvic lymphadenectomy in a nulliparous patient with cervical adenocarcinoma: A case report
por: Galati, Elpis, et al.
Publicado: (2019)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to
por: Carofiglio, Francesca, et al.
Publicado: (2020)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
por: Thomakos, Nikolaos, et al.
Publicado: (2010)

Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Kunakom, Sylvia, et al.
Publicado: (2019)

Prolapse of a large pedunculated uterine myoma
por: Papapanagiotou, Ioannis K., et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: Liontos, M., et al.
Publicado: (2021)

Dietary Nitrate: Where Is the Risk?
por: L’hirondel, Jean-Louis, et al.
Publicado: (2006)

Bisphenol A: Where to Now?
por: Bucher, John R.
Publicado: (2009)

Where Next for Genetics and Genomics?
por: Tyler-Smith, Chris, et al.
Publicado: (2015)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6e70bo87htmqbbq1pq6si8c2fe